'CAR T cell therapy for cancer: Pre-clinical delivery, clinical testing and post-clinical models to investigate CAR-T efficacy and toxicity issue'

'CAR T cell therapy for cancer: Pre-clinical delivery, clinical testing and post-clinical models to investigate CAR-T efficacy and toxicity issue'
-

This is a past event

Dr David Gilham, Institute of Cancer Sciences, University of Manchester

Immunity, Infection and Inflammation Seminar Programme

Speaker
Dr David Gilham
Hosted by
Dr Neil Young
Venue
Institute of Medical Sciences - Level 7 Conference Room